Daewon Pharmaceutical Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 1958-01-07
- Employees
- 1.2K
- Market Cap
- -
- Website
- http://www.daewonpharm.com
Clinical Trial to Evaluate the Pharmacokinetic Characteristics of DW5221 and DW5221-R
- First Posted Date
- 2023-11-28
- Last Posted Date
- 2023-11-28
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT06147908
- Locations
- 🇰🇷
Chungbuk National University Hospital, Cheongju-si, Korea, Republic of
Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 252
- Registration Number
- NCT05970679
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Clinical Trial to Evaluate the Efficacy and Safety of DWKH
- First Posted Date
- 2023-01-13
- Last Posted Date
- 2023-01-13
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 186
- Registration Number
- NCT05683951
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-01-31
- Last Posted Date
- 2022-01-31
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT05214677
- Locations
- 🇰🇷
Chungbuk National University Hospital, Cheongju-si, Korea, Republic of
A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809-T2
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-01-31
- Last Posted Date
- 2022-01-31
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 37
- Registration Number
- NCT05214690
- Locations
- 🇰🇷
Chungbuk National University Hospital, Cheongju-si, Korea, Republic of
To Evaluate the Efficacy and Safety of DW1903 in Acute and Chronic Gastritis Patient
- First Posted Date
- 2021-12-20
- Last Posted Date
- 2021-12-20
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 332
- Registration Number
- NCT05163756
- Locations
- 🇰🇷
Korea University Ansan Hospital, Seoul, Korea, Republic of
Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903
- First Posted Date
- 2021-12-13
- Last Posted Date
- 2021-12-13
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 31
- Registration Number
- NCT05155072
- Locations
- 🇰🇷
Chungbuk National University Hospital, Cheongju-si, Korea, Republic of
Phase 3 Clinical Trial to Evaluate of the Efficacy and Safety of DW9801 in Patients With Primary Dysmenorrhea
- First Posted Date
- 2020-09-09
- Last Posted Date
- 2020-09-09
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT04541134
Clinical Trial to Evaluate the Efficacy and Safety of 'DW1601' in Acute Bronchitis
- First Posted Date
- 2020-02-07
- Last Posted Date
- 2020-02-07
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 204
- Registration Number
- NCT04260555
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
Clinical Trial to Evaluate the Efficacy and Safety of 'Pelubiprofen Controlled Released Tab.' in Acute Traumatic Injury
Phase 3
- Conditions
- Interventions
- First Posted Date
- 2019-03-14
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 94
- Registration Number
- NCT03874247
- Locations
- 🇰🇷
Severance Hospital, Seoul, Seodaemun-gu, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath